FASEB JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2023-01-10 ms7000000175049819 来自湖南省

请问一审大概要多久，孩子急着毕业找工作

42 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2022-05-08 ms7000001099295732

请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊

44 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2022-05-05 ms7000001099295732

我的 under consideration 一个多月了，请问大家有相同的情况吗

39 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2022-06-09 ms1000000838317809

请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？

41 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2020-02-11 高山上的磐石

不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表:
交了审稿费一定会送外审嘛？

137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？

162 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2021-09-01 哆啦A梦9501

想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗

55 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2023-12-06 maitianli 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学
经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。

30 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2021-04-03 Pentazocine

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。#肿瘤#

131 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2024-03-12 ms8000001041161059 来自上海

Quality control failed什么意思

16 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109709, encodeId=86592109e09e3, content=请问一审大概要多久，孩子急着毕业找工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Jan 10 18:57:36 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1217895, encodeId=6ce4121e8958a, content=请问这个杂志是不是没有Under review 模式啊，我的stage 框里面显示是三个out of review 接着三个Under consideration，但是界面current stage 显示的是 Under consideration，到底什么意思啊看不懂了。。。。。到底是在审稿中还是还在找审稿人啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Sun May 08 17:06:07 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217184, encodeId=d5eb121e18472, content=我的 under consideration 一个多月了，请问大家有相同的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Thu May 05 21:43:13 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225455, encodeId=509d1225455e1, content=请问各位前辈，我投稿后近一个月了，一直是under consideration，也没有out for review，是有什么问题吗？有没有一样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bff05535630, createdName=ms1000000838317809, createdTime=Thu Jun 09 15:39:53 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584569, encodeId=9fdf58456913, content=不一定，但是如果拒绝会秒拒137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, beContent=137****6823暂无昵称 2020-02-09 00:00:00 发表: 交了审稿费一定会送外审嘛？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Tue Feb 11 00:00:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013419, encodeId=62f510134198b, content=想问问一共会有几个out of review,每一个out of review都代表一个外审专家的意见吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAvtsZsukLwkdHaPA2T6ldPVPf4tzd5Ph1GcSYic7icicl4dViciaY7AsMOe8gy6uqXRDMOo4NTFicqiagw/132, createdBy=e32a2561878, createdName=哆啦A梦9501, createdTime=Wed Sep 01 10:30:34 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆)]

2024-01-12 ms6083841171193720 来自重庆

请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志

30 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务